GUFIC BIOSCIENCES
|
The Current P/E Ratio of GUFIC BIOSCIENCES is 55.93.
Share Price | ₹345.0 | Oct 23,2025 |
Market Cap | ₹3,459.8 Cr | |
Earnings-TTM | ₹61.9 Cr | TTM-Consolidated Results |
Price/Earnings | 55.93x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of GUFIC BIOSCIENCES
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹3,459.8 Cr] as on Oct 23,2025
(/) Earnings [ ₹61.9 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 55.93x ]
Thus, for GUFIC BIOSCIENCES , the investors are currently willing to pay 55.93 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of GUFIC BIOSCIENCES !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of GUFIC BIOSCIENCES over the last five years.
Historical PE (Price/Earnings) ratio chart of GUFIC BIOSCIENCES
PE Ratio Performance Analysis for GUFIC BIOSCIENCES
- GUFIC BIOSCIENCES 's p/e ratio for fiscal years ending Mar2025 to Mar2024 averaged 40.70x.
- GUFIC BIOSCIENCES 's operated at median p/e ratio of 48.44x from fiscal years ending March 2018 to 2022.
- Looking back at the last 2 fiscal years, GUFIC BIOSCIENCES 's p/e ratio peaked in Mar2025 at 48.44x.
- GUFIC BIOSCIENCES 's p/e ratio hit its five-year low in Mar2024 of 32.96x.
How does GUFIC BIOSCIENCES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
GUFIC BIOSCIENCES | 61.87 | 55.93 | 3,459.8 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 10,411.50 | 38.92 | 405,248.0 |
DIVIS LABORATORIES LTD | 2,306.00 | 75.53 | 174,177.0 |
CIPLA LTD | 5,406.81 | 24.58 | 132,898.0 |
TORRENT PHARMACEUTICALS LTD | 2,002.00 | 61.15 | 122,428.0 |
DR REDDYS LABORATORIES LTD | 5,726.70 | 18.65 | 106,818.0 |
MANKIND PHARMA LTD | 1,905.51 | 53.05 | 101,095.0 |
ZYDUS LIFESCIENCES LTD | 4,637.80 | 21.87 | 101,408.0 |
LUPIN LTD | 3,722.18 | 23.81 | 88,616.1 |
AUROBINDO PHARMA LTD | 3,417.93 | 18.67 | 63,827.2 |
ABBOTT INDIA LTD | 1,452.29 | 44.04 | 63,959.3 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs GUFIC BIOSCIENCES 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 18.65x |
Max industry PE | 75.53x |
Median industry PE | 38.92x |
Average industry PE | 39.66x |
You may also like the below Video Courses